January 2012 — OncoGenex, located in Vancouver, Canada and Seattle, Washington, has subscribed to R&D Logic software and services for planning and tracking, and financial reporting. OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.

September 2011 — RealD, located in Beverly Hills, California, has subscribed to R&D Logic software services to manage planning, tracking and time collection for their Colorado based Research & Development division. RealD is a leading global licensor of stereoscopic (three-dimensional), or 3D, technologies. Its extensive intellectual property portfolio enables a premium 3D viewing experience in the theater, the home and elsewhere.

September 2011 — Vitapath Genetics, Inc., located in Foster City, California, has subscribed to R&D Logic software services to manage planning, tracking, time collection and corporate reporting. VitaPath Genetics is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease.

August 2011 — Affymax, located in Palo Alto, California, has subscribed to R&D Time software services to manage time collection, FTE and collaborations reporting. Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions.The company’s product candidate, peginesatide (formerly known as HematideTM), has been investigated in Phase 3 trials for the potential treatment of anemia associated with chronic renal failure.

May 2011 — NovaBay, located in Emeryville, California, has subscribed to R&D Time software services to manage time collection and collaborations' reporting. NovaBay is a clinical stage biotechnology company focused on developing its proprietary and patented topical Aganocide compounds.

November 2010 — Anthera, located in Hayward, California, has subscribed to R&D Logic software and services for planning and tracking, and financial reporting. Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases.

October 2010 — Adamas, a long term customer of R&D Logic, has added R&D Time to their suite of services. R&D Time is being utilized to collecting and tracking time effort, with an emphasys on NIH grants. Adamas Pharmaceuticals is an emerging pharmaceutical company focused on developing small molecule Advantaged Therapeutics. Adamas Pharmaceuticals is headquartered in Emeryville, California, with operations in Bangalore, India.

September 2010 — Trius Therapeutics, located in San Diego, California, has chosen R&D Logic software for corporate and research contracts planning and tracking, budgeting and forecasting. Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections.

September 2010 — Athersys, located in Cleveland, Ohio, has subscribed to R&D Logic software and services for corporate planning and tracking, and financial reporting. Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas.

June 2010 — Prognosys Biosciences, located in La Jolla, California, has chosen R&D Logic software for corporate planning and tracking, financial reporting, and time collection. Prognosys is an early-stage biotechnology company focusing on the promising and rapidly developing field of personalized medicine. Prognosys carries out R&D in the area of novel assays and biomarker discovery, and uses next-generation sequencing technologies for the analysis of complex systems.

May 2010 — Hyperion Therapeutics, Inc., located in South San Francisco, California, has subscribed to R&D Logic software services to manage planning and tracking of corporate revenues, expenses and resources. Hyperion Therapeutics is a privately held pharmaceutical company focused on the development of treatments that address critical unmet needs in the areas of gastroenterology and hepatology.

November 2009 — MacroGenics, Inc., located in Rockville, Maryland, has subscribed to R&D Logic software services to manage world-wide corporate planning and tracking,budgeting and forecasting, and financial reporting. MacroGenics'mission is to discover, develop and deliver to patients novel biologics for the treatment of autoimmune disorders, cancer and infectious diseases.

November 2009 — Facet Biotech, located in Redwood City, California, has subscribed to R&D Time software services to manage corporate budgeting and forecasting, time collection, and project FTE reporting. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc. Combining expertise in antibody engineering with a disciplined, biology-driven research approach, Facet Biotech is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs.

October 2009 — Inviragen, Inc.located in Fort Collins, Colorado, has subscribed to R&D Time software services to manage world-wide time collection and grant reporting. Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases worldwide.

June 2009 — KaloBios Pharmaceuticals, located in South San Francisco, California, has subscribed to R&D Time software services to manage corporate time collection and project FTE reporting.KaloBios uses its biologic capabilities and its proprietary platform technology to develop first-in-class human antibody therapeutics.

May 2009 — Medivation, Inc., located in San Francisco, California, has subscribed to R&D Logic software services for planning and tracking expenses and resources at the corporate and project portfolio levels as well as for collecting and tracking R&D project time to collaborators and to internal management. Medivation is is a biopharmaceutical company with small molecule drugs in clinical development to treat three large, unmet medical needs.

April 2009 — Portola Pharmaceuticals located in South San Francisco, California, has subscribed to R&D Time software service to manage all corporate time collection, financial reporting, and project FTE reporting. Portola is discovering and developing novel therapeutics to meet patient needs in cardiovascular, inflammation, and oncology indications.

April 2009 — Nevro Corporation, located in Palo Alto, California, has subscribed to R&D Manage software service for planning and tracking expenses and resources at the corporate and project portfolio levels. Nevro is a medical device company developing novel neuromodulation therapies for multiple indications.

February 2009 — Portola Pharmaceuticals located in South San Francisco, California, has subscribed to R&D Time software service to manage all corporate time collection, financial reporting, and project FTE reporting. Portola is discovering and developing novel therapeutics to meet patient needs in cardiovascular, inflammation, and oncology indications.

December 2008 — Ambrx, located in La Jolla, California, has subscribed to R&D Time software service to collect, track and report project effort. Special emphasys will be put on tracking effort by collaborator. Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics.